AKR1C1 and head and neck squamous cell carcinoma: To understand the AKR1C1 function in HNSCC related cisplatin-resistance, we performed AKR1C1 shRNA silencing in high AKR1C1 expressing cells, FaDu and HSC-2 (Fig. 2a and d).